6th ESUR Teaching Course on Prostate MRI, Berlin 2016

Similar documents
4 th International Workshop on Diagnostic and Interventional Prostate MRI April 2019, Thursday 11 th and Friday 12 th, Paris, France

Problems: TRUS Bx. Clinical questions in PCa. Objectives. Jelle Barentsz. Prostate MR Center of Excellence.

ASKLEPIOS Course MULTIDISCIPLINARY APPROACH TO CANCER IMAGING. Education in partnership. November 5 6, 2018 Rome/Italy. myesr.

Detection, Screening and. Jelle Barentsz, Radboudumc, Nijmegen, NL

Prostate Cancer DFP Case of the Week

ASKLEPIOS Course ADVANCED ONCOLOGIC IMAGING. Education in partnership. September 30 October 1, 2016 Kazan/Russia. myesr.org/esor

1 Uniform hyperintense signal intensity (normal). 2 Linear (arrow), wedge-shaped, or diffuse mild hypointensity, usually indistinct margin.

PROSTATE MRI. Dr. Margaret Gallegos Radiologist Santa Fe Imaging

Optimizing Implementation of Prostate MRI. Andrei S Purysko, M.D. Section of Abdominal Imaging & Nuclear Radiology Department

If you have aggressive cancer, you would want treatment in time for a cure.

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

PI-RADS V2 IN PRACTICE A PICTORIAL REVIEW

Register today to get the latest advancements and techniques in prostate MR imaging one of radiology s most rapidly growing fields.

Osher Mini Medical School for the Public

ESOR COURSES FOR EDiR 2017

Preliminary Programme

Prostate MRI Hamidreza Abdi, MD,FEBU Post Doctoral Fellow Vancouver Prostate Centre UBC Department of Urologic Sciences May-20144

Multiparametric MR Imaging of the Prostate after Treatment of Prostate Cancer

Prostate Biopsy in 2017

Effect of intravenous contrast medium administration on prostate diffusion-weighted imaging

Prostate Cancer MRI. Accurate Diagnosis and Treatment. PSA to Prostate MRI. for patients and curious doctors

Essential Initial Activities and Clinical Outcomes

Anatomic Imaging of Prostate Cancer

Aims and objectives. Methods and materials. Background

PI-RADS v2 for predicting prostate cancer Gleason score at final pathology after radical prostatectomy

MRI and Fusion biopsies. K Sahadevan Consultant Urologist

Prostate cancer caused necrosis segmentation and registration system for perfusion analysis via ethrive imaging

Prostate MRI based on PI-RADS version 2: how we review and report

Magnetic Resonance Imaging of Prostate Cancer: Approach, Local Staging and Therapeutic Impact

Diagnosis and management of prostate cancer in the

MR-US Fusion Guided Biopsy: Is it fulfilling expectations?

Irreversible Electroporation for the Treatment of Recurrent Prostate Cancer

The role of T2-weighted imaging in detecting prostate cancer of the central zone in 3T multiparametric magnetic resonance examination

Multiparametric MRI diagnostic value in a case of prostate cancer

THURSDAY, DECEMBER 13, 2018

What is multiparametric-mri of the prostate and why do we need it?

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging

MRI-targeted, transrectal ultrasound-guided prostate biopsy for suspected prostate malignancy: A pictorial review

My biopsy shows prostate cancer: How bad is it? How to stage prostate cancer

GALEN ADVANCED Course

PI-RADS v2.1 PI-RADS. Prostate Imaging Reporting Version 2.1. American College of Radiology 2019 i PI-RADSv2.1

The current status of MRI in prostate cancer

Pieter De Visschere, Eva Pattyn, Piet Ost, Tom Claeys, Nicolaas Lumen and Geert Villeirs

PI-RADS version 2 - what we need to know

MR-US Fusion. Image-guided prostate biopsy. Richard E Fan Department of Urology Stanford University

URO. THE GLOBAL PROSTATE CANCER MEETING Hot Spots in Prostate Cancer MADRID SEPTEMBER Hospital Universitario Puerta de Hierro Majadahonda

Transformation of the South West Prostate Cancer Diagnostic Pathway. 14 th May 2018

PCa Commentary. Executive Summary: The "PCa risk increased directly with increasing phi values."

Multiparametric Prostate MRI: PI-RADS V.2

Correspondence should be addressed to Po-Fan Hsieh;

Molecular Research in Urology 2014: Update on PET/MR Imaging of the Prostate

Prostate biopsy: MR imaging to the rescue

THURSDAY, DECEMBER 13, 2018

Prostate Focal Therapy: What s on the Horizon? Thomas J Polascik, MD FACS

International London Uropathology Conference 2014

Stephen McManus, MD David Levi, MD

Evolution of prostate MRI: from multiparametric standard to less-is-better and different-is better strategies

PELVIC MRI COURSE. November 12-14, 2016

ESOR COURSES FOR EDiR 2018 CHEST IMAGING

Structured MRI report in prostate cancer using the PIRADS criterias: the bridge between the imagist and the clinician

Prostate MRI for local staging and surgical planning in prostate cancer

PELVIC MRI COURSE. November 12-14, 2016

Friday 25 May EAU Lecture Where are we in male infertility in 2018? J.O.R. Sonksen, Herlev (DK)

ESOR COURSES FOR EDiR 2018

Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer

PSA nadir post LDR Brachytherapy and early Salvage Therapy. Dr Duncan McLaren UK & Ireland Users Group Meeting 2016

Prostate cancer smart screening, precision diagnosis, personalised treatment'

What is Multiparametric-MRI of the Prostate and Why Do We Need It?

Prostate MRI: Screening, Biopsy, Staging, and Ablation

Prostate Imaging An Update

Local Organiser: Madhup Rastogi, Radiation Oncologist, Ram Manohar Lohia Institute of Medical Sciences, Lucknow

ASKLEPIOS Course CARDIAC IMAGING. Education in partnership. October 17 19, 2018 Graz/Austria. myesr.org/esor

Research Article Evaluation of the PI-RADS Scoring System for Classifying mpmri Findings in Men with Suspicion of Prostate Cancer

Keywords Prostate, cancer, magnetic resonance imaging (MRI), diffusion-weighted imaging (DWI), Gleason score

Hakozaki et al. BMC Urology (2017) 17:117 DOI /s

GRAZ TUTORIAL. Education in partnership. October 15 19, 2018 Graz/Austria. myesr.org/esor

Standards for MRI reporting the evolution to PI-RADS v 2.0

Date Modified: May 29, Clinical Quality Measures for PQRS

Interobserver agreement in prostate cancer detection using multiparametric MRI

PI-RADS classification: prognostic value for prostate cancer grading

Cognitive target MRI-TRUS fusion biopsies of MRI detected PIRADS 4 and 5 lesions

BI-RADS, C-RADS, GI-RADS, LI-RADS, Lu-RADS, TI-RADS, PI-RADS. The long and winding road of standardization

Pitfalls in Interpreting mp-mri of the Prostate: A Pictorial Review with Pathologic Correlation

ASKLEPIOS Course. August 24, 2018 Recife/Brazil

Prostate MRI: Who needs it?

Update in Breast Imaging

Multiparametric 3T MR imaging of the prostate - acquisition protocols and image evaluation

Utility of Prostate MRI. John R. Leyendecker, MD

GRAZ TUTORIAL. Education in partnership. October Graz/Austria. myesr.org/esor

Technique, research and benefits

Genitourinary Imaging Original Research

Urologic Oncology Section

PI-RADS v2: Current standing and future outlook

What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen).

D. J. Margolis 1, S. Natarajan 2, D. Kumar 3, M. Macairan 4, R. Narayanan 3, and L. Marks 4

The Evolving Role of MRI in Prostate Cancer Management: Detection, Staging, Surveillance,

Prostate Cancer Imaging: most common pitfalls in multiparametric Magnetic Resonance

MUSCULOSKELETAL SONOGRAPHY COURSE FOR RHEUMATOLOGISTS - BASIC LEVEL - June 27 th 29 th, 2013 Innsbruck, Austria

Transcription:

6th ESUR Teaching Course on Prostate MRI, Berlin 2016 Friday, June 10, 2016 8:00 am Registration 8:45 am Welcome Address B. Hamm and H. Thoeny 9:00 10:20 am Session 1 "ABC of the Prostate and mp- MRI: How We Do It (Part I)" Moderator: H. Thoeny 20 min Prostate Anatomy, Metabolism and Function (Normal Prostate and BPH) G. Villeirs 15 min Examination Techniques, Imaging Protocols and Patient Preparation P. Asbach (Berlin) 15 min Functional/Morphologic Imaging: DWI (Including which b- Values are Needed) S. Hirsch/M. Taupitz (Berlin) 15 min Functional Imaging: Dynamic Contrast- enhanced MRI T. Franiel (Jena) 15 min Questions 10:20 11.00 am Coffee Break

11:00 12:30 am Session 2 "Mp- MRI: How We Do It (Part II)" Moderator: V. Løgager 20 min PI- RADS version 2.0 H. Thoeny 20 min Detection of Prostate Cancer (Including Assessment of Aggressiveness) J. Richenberg 15 min T2 Mimics of Prostate Cancer: Peripheral Zone and the Nightmare of BPH J. Vilanova 15 min Pitfalls of mp- MRI of the Prostate V. Panebianco 20 min Questions 12:30 1:30 pm Lunch 1:30 2:30 pm Hands- on Workshops I (Basic) Team Charité P. Asbach, A. Baur, M. Haas, B. Hamm, M. Wagner 2:30 3:30 pm Hands- on Workshops II (Intermediate) A. Baur, M. Haas, V. Løgager, V. Panebianco, H. Thoeny 3:30 4:00 pm Coffee Break

4:00 5:00 pm Session 3 "MRI of the Prostate: Detection and Beyond" Moderator: J. Vilanova 15 min Local Staging G. Villeirs 10 min Nodal Staging H. Thoeny total: 15 min Emerging Techniques - MR Elastography P. Asbach - Radiomics T. Penzkofer 15 min Questions Walking over to hands- on workshop rooms 5:00 6:00 pm Hands- on Workshops (Advanced) P. Asbach, F. Cornud, B. Hamm, J. Vilanova, G. Villeirs 6:00 8:00 pm Cases for self- study available

Saturday, June 11, 2016 9:00 10:50 am Session 4 "Prostate MRI in the Clinical Scenario" Moderators: B. Hamm and V. Panebianco 20 min Prostate Cancer: Clinical Needs that Can be Addressed with Imaging J. Busch 30 min Histopathology: What the Radiologist Needs to Know and Challenges with the Gleason Score G. Sauter 20 min How Can mp- MRI Change the Management of Prostate Cancer? A. Padhani 15 min PI- RADS version 3.0: What Next? J. Barentsz 25 min Discussion 10:50 11:30 am Coffee Break

11:30 am 1:00 pm Session 5 "Mp- MRI of the Prostate: Lots of Challenges" Moterators: J. Richenberg and H. Thoeny 20 min Sense and Nonsense of DCE and MRSI G. Villeirs 15 min Cutting Edge Techniques: Multiple and High b- Value DWI, IVIM, ADC, Kurtosis H.- P. Schlemmer 10 min Discussion 45 min Discussion Round 1 Moderator: J. Richenberg Topic 1: Dynamic Contrast MRI Should be Used in All Men Undergoing mp- MRI for Prostate Cancer Detection Pro: V. Panebianco and A. Padhani Contra: F. Cornud and J. Vilanova (e.g., 3 min each 1 st round and then 2 min each 2 nd round (20 min), vote = 25 min) 1:00 2:00 pm Lunch Topic 2: PI- RADS 2 is a Fancy Radiological Construct but not a Practical Clinical Tool Yes: H.- P. Schlemmer and H. Thoeny No: J. Barentsz and G. Villiers (e.g., 4 min each (16 min), vote = 20 min) 2:00 3:20 pm Session 6 "Image or Tissue: What First?" Moderators: H. Cash and F. Cornud 20 min MRI as First- Line Test before Prostate Biopsy B. Hamm 15 min Mp- MRI: Influence on Biopsy Patterns and Techniques J. Richenberg total: 30 min How we Do it: (10 min for each presentation) - MR- guided Biopsy A. Baur - MR- US Fusion Biopsy Th. Fischer - Comment: F. Cornud 15 min Discussion 3:20 4:00 pm Coffee Break

4:00 4:30 pm Discussion Round 2 Moderator: A. Padhani Topic 3: Image- guided Biopsy: Targeted Biopsy only - or - in Combination with Systematic Biopsy? Only: G. Sauter In combination: H. Cash (e.g., 7 min each plus discussion) 4:30 6:30 pm Session 7 "Mp- MRI Beyond Disease Detection" Moderators: J. Vilanova and G. Villeirs 30 min The Role of MRI in Focal Therapy - Update and MR- guided Focussed Ultrasound (MRgFUS) (20 min) H. Ahmed - Neither Heat Nor Cold: Irreversible Electroporation (IRE) (10 min) Th. Fischer 25 min MRI in Recurrence Detection - After Radical Prostatectomy (10 min) H. Thoeny - After Radiotherapy and under Hormone Therapy (15 min) V. Panebianco 15 min MRI in Active Surveillance: When and How? J. Richenberg 15 min Imaging Follow- up: Advanced Disease in Light of New Second- and Third- Line Therapies A. Padhani 20 min PSMA- PET- CT/MR: The New Kid on the Block H.- P. Schlemmer 15 min Discussion 6:30 pm Closing Remarks B. Hamm